Depo-Provera · DIN 02523493 · 150 mg/mL · injection solution-1mL pre-filled syringe
Temporary benefitMarketed · checked November 18, 2026
StatusTemporary benefit
Write on scriptcheck temporary-benefit rules below
Patient paysNot paid by ODB 65 and over; see alternatives
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Depo-Provera · DIN 02523493
Manufacturer: Pfizer Canada Inc.; listing date 2022-08-31
Health Canada: Marketed since 2022-04-25 · brand DEPO-PROVERA · ATC G03AC06 MEDROXYPROGESTERONE · form Suspension · route Intramuscular · ingredients MEDROXYPROGESTERONE ACETATE 150 MG/ML · company Pfizer canada ulc · schedule Prescription
Depo-Provera: Formulary list price $34.79 per unit (the source does not state the unit; exact figure $34.7886). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02523493)
Source record
DIN 02523493: Depo-Provera
Raw flags: sec3c=Y
Item: 683200118; group id 801; item number 1958; lccId None; manufacturer id PFI
Source form: Inj Sol-1mL Pref Syr; strength: 150mg/mL
Recorded listing: Temporary benefit (shortage substitute)
Source prices (unrounded): $34.7886; ministry $34.7886
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02523493
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101256
Shortage status: not checked (no credentials)